4.5 Article

Deletion of endoplasmic reticulum stress-responsive co-chaperone p58IPK protects mice from diet-induced steatohepatitis

期刊

HEPATOLOGY RESEARCH
卷 48, 期 6, 页码 479-494

出版社

WILEY
DOI: 10.1111/hepr.13052

关键词

endoplasmic reticulum stress; fatty liver; hepatocyte apoptosis

资金

  1. National Institute of Diabetes and Digestive and Kidney Disease [DK 97178, DK107402, DK111378]
  2. Robert and Elizabeth Strickland Career Development Award from Division of Endocrinology of the Mayo Foundation for Medical Education and Research
  3. Gilead Sciences Research Scholars Program in Liver Disease
  4. Palumbo Foundation
  5. Edward C. Kendall Research Fellowship Award of the Mayo Foundation for Medical Education and Research

向作者/读者索取更多资源

Aim: Activation of PKR-like endoplasmic reticulum kinase (PERK), an endoplasmic reticulum stress sensor, is a feature of non-alcoholic steatohepatitis (NASH), yet regulators of PERK signaling remain undefined in this context. The protein p58(IPK) regulates PERK; however, its role in NASH has not been examined. The aim of this study was to assess the in vivo role of p58(IPK) in the pathogenesis of dietary NASH. Methods: Parameters of hepatocyte cell death, liver injury, inflammation, fibrosis, indirect calorimetry and PERK activation were assessed in p58(IPK) knockout (p58(ipk-/-)) mice and their wild-type littermate controls. All animals were fed a diet enriched in fat, fructose, and cholesterol (FFC) for 20 weeks. Results: Activation of PERK was attenuated in FFC-fed p58(ipk-/-) mice. Accordingly, FFC-fed p58(ipk-/-) mice showed a reduction in hepatocyte apoptosis and death receptor expression, with a significant reduction in serum alanine transaminase values. Correspondingly, macrophage accumulation and fibrosis were significantly lower in FFC-fed p58(ipk-/-) mice. Conclusion: We have shown that, in an in vivo dietary NASH model, p58(IPK) mediates hepatocyte apoptosis and liver injury, likely through PERK phosphorylation. In the absence of p58(IPK), PERK phosphorylation and NASH are attenuated. Inhibition of hepatic p58(IPK) could be a future target for NASH therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据